FDA approves first treatment for Erdheim-Chester Disease
On Nov. 6, the U.S. Food and Drug Administration (FDA) expanded approval of Zelboraf (vemurafenib) to treat certain adult patients with Erdheim-Chester Disease. (more…)
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.